Is this your firm? Get featured or correct your listing →
At a glance
Leaps by Bayer appears in 2 funding rounds tracked by ValueAddVC since 2026. Its most recent tracked deal was Souffle Therapeutics' $135M Series B round (Oct 13, 2026).
Recent changes
- Oct 13, 2026Oct 13, 2026Invested in Souffle Therapeutics (Series B, $135M) FinancialContent
- Jul 2, 2026Jul 2, 2026Invested in Celea Therapeutics ($180M) Celea Therapeutics
Portfolio
2 totalRecent Investment Activity
2Track record: led 0 and participated in 2 of 2 tracked venture rounds · 2 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Souffle Therapeutics | Series B | Participated | $135M | — | Fidelity InvestmentsunverifiedARCH Venture PartnersunverifiedBessemer Venture PartnersunverifiedJanus Henderson InvestorsunverifiedLeaps by BayerunverifiedPolaris PartnersunverifiedTemasekunverifiedVida VenturesunverifiedJuvia GroupTCG Crossover ManagementBB BiotechBalyasny Asset Management+5 more | FinancialContent |
| Jul 2, 2026 | Celea Therapeutics | funding round | Participated | $180M | — | Celea Therapeutics |
Co-Investors
9Similar Firms
overlapping sector, stage or regionLatest Pulse
Leaps by Bayer FAQ
What companies has Leaps by Bayer invested in?
Leaps by Bayer's portfolio includes Souffle Therapeutics, Celea Therapeutics.
Who does Leaps by Bayer co-invest with most?
In the rounds Value Add tracks, Leaps by Bayer most often invests alongside ARCH Venture Partners (1 shared deal), Bessemer Venture Partners (1 shared deal), Fidelity Investments (1 shared deal), Janus Henderson Investors (1 shared deal), Polaris Partners (1 shared deal).
Sources & methodologyshow
- Celea Therapeuticsprimary source1 fact
- FinancialContentresearch database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.